Mandisa Mangisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mandisa Mangisa has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Clemence Tarirai
Department of Pharmaceutical Sciences, Tshwane University of Technology, Pretoria, South Africa
1 shared publication - Douglas Kemboi
Department of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa
1 shared publication - Gerda Fouche
Department of Chemistry, University of Pretoria, Pretoria 0001, South Africa
1 shared publication - Martin Cheek
Royal Botanic Gardens, Kew, Richmond, Surrey, TW9 3AE, UK
1 shared publication - Moses Kiprotich Langat
Jodrell Laboratory, Royal Botanic Gardens
1 shared publication - Odwa Gonyela
Department of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa
1 shared publication
Latest Publications
- Open Access
- 30 September 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (10) , 1390
Ethnomedicinal Uses, Phytochemistry and Pharmacological Properties of Suregada Genus: A Review
Plants of the Suregada Roxb. ex Rottler (formerly Gelonium Roxb. ex Willd) are utilized to treat various ailments, namely, hepatic, gum diseases, pyrexia, eczema, and venereal diseases. This review links the reported compounds to ethnomedicinal uses through pharmacological activities. The compounds possess anticancer, anti-allergic, antibacterial, anti-inflammatory, antioxidant, and anti-HIV properties. From the previous reports, 32 known species of the Suregada genus have been investigated morphologically, and nine were investigated for their phytochemistry and pharmacology. Phytochemistry, ethnomedicinal, and pharmacological uses of the other 23 Suregada species are not known and/or not reported. In this review, abietane diterpenoids are the main compounds expressed by the Suregada, accounting for 71 of the 114 reported compounds. Ten triterpenoids and sterols, one aliphatic, two lignans, five flavonoids, and twenty-one nitrogen-containing compounds have been reported from the genus.
- 30 September 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (10) , 1390
Open AccessEthnomedicinal Uses, Phytochemistry and Pharmacological Properties of Suregada Genus: A Review
Plants of the Suregada Roxb. ex Rottler (formerly Gelonium Roxb. ex Willd) are utilized to treat various ailments, namely, hepatic, gum diseases, pyrexia, eczema, and venereal diseases. This review links the reported compounds to ethnomedicinal uses through pharmacological activities. The compounds possess anticancer, anti-allergic, antibacterial, anti-inflammatory, antioxidant, and anti-HIV properties. From the previous reports, 32 known species of the Suregada genus have been investigated morphologically, and nine were investigated for their phytochemistry and pharmacology. Phytochemistry, ethnomedicinal, and pharmacological uses of the other 23 Suregada species are not known and/or not reported. In this review, abietane diterpenoids are the main compounds expressed by the Suregada, accounting for 71 of the 114 reported compounds. Ten triterpenoids and sterols, one aliphatic, two lignans, five flavonoids, and twenty-one nitrogen-containing compounds have been reported from the genus.